Plus Therapeutics (PSTV) Other Non-Current Assets (2010 - 2026)
Plus Therapeutics (PSTV) reported Other Non-Current Assets of $147000.0 for Q1 2026, up 673.68% year-over-year from $19000.0 in Q1 2025, and up 19.51% quarter-over-quarter from $123000.0 in Q4 2025.
Plus Therapeutics (PSTV) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 17 years of Other Non-Current Assets data on file, last reported at $147000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $147000.0, up 673.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $147000.0 (up 673.68% YoY), and the FY2025 annual result was $123000.0, up 925.0% from the prior year.
- Other Non-Current Assets grew to $147000.0 in Q1 2026 per PSTV's latest filing, from $123000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $147000.0 in Q1 2026 and troughed at $12000.0 in Q3 2022.
- A 5-year average of $37117.6 and a median of $32000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets plunged 62.5% in 2024, then surged 925.0% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $12000.0 in 2022, then jumped by 166.67% to $32000.0 in 2023, then sank by 62.5% to $12000.0 in 2024, then surged by 925.0% to $123000.0 in 2025, then increased by 19.51% to $147000.0 in 2026.
- Business Quant data shows PSTV's Other Non-Current Assets at $147000.0 in Q1 2026, $123000.0 in Q4 2025, and $45000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | 147,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 147,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 16,000.00 |